Veronica Gibaja

1.6k total citations
13 papers, 270 citations indexed

About

Veronica Gibaja is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Veronica Gibaja has authored 13 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Veronica Gibaja's work include Virus-based gene therapy research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Veronica Gibaja is often cited by papers focused on Virus-based gene therapy research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Veronica Gibaja collaborates with scholars based in United States, Switzerland and Sri Lanka. Veronica Gibaja's co-authors include David A. Ruddy, Åsa Öhagen, David King, Tomáš Rejtar, Zhengtian Yu, Huili Zhai, C. Paris, Nicholas Keen, Hing Man Chan and Joshua M. Korn and has published in prestigious journals such as Cancer Research, Oncogene and Genome Research.

In The Last Decade

Veronica Gibaja

12 papers receiving 254 citations

Peers

Veronica Gibaja
Bradley C. Pietz United States
Neal Brown United States
Douglas S. Smoot United States
Nathalie Dussault Canada
Winnie Chong United Kingdom
Ryan J. Whitmarsh United States
Mario Martínez‐Florensa Spain
Juliana B. Woodcock United States
Torahiko Makino Japan
Miriam Groß Germany
Bradley C. Pietz United States
Veronica Gibaja
Citations per year, relative to Veronica Gibaja Veronica Gibaja (= 1×) peers Bradley C. Pietz

Countries citing papers authored by Veronica Gibaja

Since Specialization
Citations

This map shows the geographic impact of Veronica Gibaja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Gibaja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Gibaja more than expected).

Fields of papers citing papers by Veronica Gibaja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Gibaja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Gibaja. The network helps show where Veronica Gibaja may publish in the future.

Co-authorship network of co-authors of Veronica Gibaja

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Gibaja. A scholar is included among the top collaborators of Veronica Gibaja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Gibaja. Veronica Gibaja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nguyen, Lily L., Zachary L. Watson, Raquel Ortega, et al.. (2024). EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner. Molecular Cancer Research. 22(12). 1117–1127.
2.
Triboulet, Robinson, Michael J. Steinbaugh, Christina Bracken, et al.. (2024). Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer. Molecular Cancer Therapeutics. 23(12). 1779–1788. 1 indexed citations
3.
Nguyen, Lily L., Zachary L. Watson, Raquel Ortega, et al.. (2024). Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation. Molecular Cancer Therapeutics. 23(9). 1332–1347. 3 indexed citations
4.
Fernández‐Barrena, Maite G., José M. Herranz, Felipe Prósper, et al.. (2023). Antitumoral activity of the G9a inhibitor EZM8266 in hepatocellular carcinoma: potential for combination with immune checkpoint inhibitors. Journal of Hepatology. 78. S526–S526. 1 indexed citations
5.
Keats, Jeffrey, Weiqing Chen, Cuyue Tang, et al.. (2021). Abstract 1161: EZH2 inhibitor tazemetostat demonstrates activity in preclinical models of Bruton's tyrosine kinase inhibitor-resistant relapsed/refractory mantle cell lymphoma. Cancer Research. 81(13_Supplement). 1161–1161. 3 indexed citations
6.
Zhou, Qianhe, Adnan Derti, David A. Ruddy, et al.. (2015). A Chemical Genetics Approach for the Functional Assessment of Novel Cancer Genes. Cancer Research. 75(10). 1949–1958. 57 indexed citations
7.
Gibaja, Veronica, Joshua M. Korn, David A. Ruddy, et al.. (2015). Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors. Oncogene. 35(5). 558–566. 107 indexed citations
8.
Simons, Peter C., Susan Young, Veronica Gibaja, et al.. (2007). Duplexed, bead‐based competitive assay for inhibitors of protein kinases. Cytometry Part A. 71A(7). 451–459. 5 indexed citations
9.
Marcello, Jennifer, et al.. (2006). Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents. Transfusion. 46(9). 1580–1588. 12 indexed citations
10.
Öhagen, Åsa, et al.. (2004). Induction of latent human cytomegalovirus by conventional gamma irradiation and prevention by treatment with INACTINE PEN110. Vox Sanguinis. 87(1). 1–9. 16 indexed citations
11.
Öhagen, Åsa, et al.. (2002). Inactivation of HIV in blood. Transfusion. 42(10). 1308–1317. 18 indexed citations
12.
Öhagen, Åsa, Veronica Gibaja, Ed Kramer, et al.. (2002). Broad‐spectrum virus reduction in red cell concentrates using INACTINE™ PEN110 chemistry. Vox Sanguinis. 83(4). 313–323. 33 indexed citations
13.
Giacalone, Joseph C., Veronica Gibaja, Lei Ni, et al.. (2000). Optical Mapping of BAC Clones from the Human Y Chromosome DAZ Locus. Genome Research. 10(9). 1421–1429. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bradley C. Pietz Breakdown of academic impact, for papers by Neal Brown Breakdown of academic impact, for papers by Douglas S. Smoot Breakdown of academic impact, for papers by Nathalie Dussault Breakdown of academic impact, for papers by Winnie Chong Breakdown of academic impact, for papers by Ryan J. Whitmarsh Breakdown of academic impact, for papers by Mario Martínez‐Florensa Breakdown of academic impact, for papers by Juliana B. Woodcock Breakdown of academic impact, for papers by Torahiko Makino Breakdown of academic impact, for papers by Miriam Groß
Rankless by CCL
2026